If you would like to inquire about all open trials, please contact 919.681.4800.
3 trials identified.
Tissue and Serum Acquisition Protocol for Molecular Analysis and Cell Culture in Patients Undergoing Parathyroid Surgery. Phase: N/A Sponsor: PI initiated Principal Investigator: James Koh Contact: Endocrine Oncology Clinical Research Office Phone: 919 .ÂÂÂ681.1478 Reference Number: 00046210
Thyroid Cancer and Polybrominated Diphenyl Ether (PBDE) Exposure Phase: N/A Sponsor: Internal Investigator Initiated Non-therapeutic/Non-interventional Principal Investigator: Heather Stapleton Contact: Endocrine Oncology Clinical Trials Office Phone: 919.681.1478 Reference Number: 00050074
RIFTOS MKI - Radioactive Iodine reFractory asymptomatic
patients in differentiated Thyroid cancer an Observational
Study to assess the use of MultiKinase Inhibitors
Phase: N/A Sponsor: Commercial / Industry (for-profit group) initiated Principal Investigator: Jennifer Choe Contact: Kristen Linney, RN Phone: 919.684.8239 Reference Number: 00064729
Ways To Give
Duke Cancer Institute constellates the world-class resources of Duke University, Duke Health and the Duke Comprehensive Cancer Center into a collaborative powerhouse. We are poised to drive a paradigm shift in the way long-established cancer centers and institutes have been waging this war.